A total of 45 patients with mild or moderate facial seborrheic dermatitis were selected from our hospital between September and September The patients were divided into three groups consisting of 15 patients each. They were treated once every 4 weeks in three consecutive rounds. Facial lesions and symptoms were observed 4 and 12 weeks after the first treatment, and adverse reactions were recorded. The combination group showed significant improvement in symptoms 4 weeks after the first treatment, while the individual treatment groups showed no significant improvement. Seborrheic dermatitis is a chronic inflammation that occurs at the base of the sebum spillage and usually manifests in the form of bright red or yellow patches with greasy scales or scabbed surfaces.
Topical Non-Pharmacological Treatment for Facial Seborrheic Dermatitis
Going to a Cleveland Clinic location? It appears as red, dry, flaky, itchy skin on the scalp and other parts of the body and is common but not contagious. Medications manage the symptoms. What is seborrheic dermatitis? Seborrheic dermatitis is a common, noncontagious, easy-to-manage skin condition. This type of dermatitis causes itchy red patches and greasy scales on your skin along with white or yellow crusty or powdery flakes on your scalp.
A more recent article on this topic is available. Patient information: See related handout on seborrheic dermatitis , written by the authors of this article. Seborrheic dermatitis is a chronic inflammatory disorder affecting areas of the head and trunk where sebaceous glands are most prominent.
Try out PMC Labs and tell us what you think. Learn More. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. Facial seborrheic dermatitis FSD is a chronic and relapsing inflammatory skin disorder occurring in areas of the face rich in sebaceous glands. It clinically manifests as erythematous scaly macules or plaques, often associated with pruritus.